{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T15:37:24Z","timestamp":1671723444205},"reference-count":42,"publisher":"Japan Society for Clinical Immunology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2177\/jsci.37.447","type":"journal-article","created":{"date-parts":[[2015,2,14]],"date-time":"2015-02-14T22:05:48Z","timestamp":1423951548000},"page":"447-453","source":"Crossref","is-referenced-by-count":2,"title":["Revertant somatic mosaicism in primary immunodeficiency diseases"],"prefix":"10.2177","volume":"37","author":[{"given":"Taizo","family":"WADA","sequence":"first","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Science, Kanazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Wada, T., Candotti, F.: Somatic mosaicism in primary immune deficiencies. Curr Opin Allergy Clin Immunol<\/i>. 8<\/b>: 510-514, 2008.","DOI":"10.1097\/ACI.0b013e328314b651"},{"key":"2","unstructured":"2) Lai-Cheong, J.E., et al.: Revertant mosaicism in skin: natural gene therapy. Trends Mol Med<\/i>. 17<\/b>: 140-148, 2011."},{"key":"3","unstructured":"3) Wahn, V., et al.: Reverse mutations-spontaneous amelioration or cure of inherited disorders? Eur J Pediatr<\/i>. 157<\/b>: 613-617, 1998."},{"key":"4","unstructured":"4) Ariga, T., et al.: A case of Wiskott-Aldrich syndrome with dual mutations in exon 10 of the WASP gene: an additional de novo one-base insertion, which restores frame shift due to an inherent one-base deletion, detected in the major population of the patient's peripheral blood lymphocytes. Blood<\/i>. 92<\/b>: 699-701, 1998."},{"key":"5","unstructured":"5) Ariga, T., et al.: Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J Immunol<\/i>. 166<\/b>: 5245-5249, 2001."},{"key":"6","unstructured":"6) Wada, T., et al.: Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Natl Acad Sci U S A<\/i>. 98<\/b>: 8697-8702, 2001."},{"key":"7","unstructured":"7) Wada, T., et al.: Multiple patients with revertant mosaicism in a single Wiskott-Aldrich syndrome family. Blood<\/i>. 104<\/b>: 1270-1272, 2004."},{"key":"8","unstructured":"8) Wada, T., et al.: Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. J Clin Invest<\/i>. 111<\/b>: 1389-1397, 2003."},{"key":"9","unstructured":"9) Konno, A., et al.: Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineages. Blood<\/i>. 103<\/b>: 676-678, 2004."},{"key":"10","unstructured":"10) Lutskiy, M.I., et al.: Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome. Blood<\/i>. 106<\/b>: 2815-2817, 2005."},{"key":"11","unstructured":"11) Du, W., et al.: A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in an Wiskott-Aldrich syndrome patient. Hum Mutat<\/i>. 27<\/b>: 370-375, 2006."},{"key":"12","unstructured":"12) Humblet-Baron, S., et al.: Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest<\/i>. 117<\/b>: 407-418, 2007."},{"key":"13","unstructured":"13) Boztug, K., et al.: Large granular lymphocyte proliferation and revertant mosaicism: two rare events in a Wiskott-Aldrich syndrome patient. Haematologica<\/i>. 92<\/b>: e43-45, 2007."},{"key":"14","unstructured":"14) Stewart, D.M., et al.: The phenomenon of spontaneous genetic reversions in the Wiskott-Aldrich syndrome: a report of the workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4-7, 2006. J Clin Immunol<\/i>. 27<\/b>: 634-639, 2007."},{"key":"15","unstructured":"15) Davis, B.R., et al.: Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndrome. Blood<\/i>. 111<\/b>: 5064-5067, 2008."},{"key":"16","unstructured":"16) Davis, B.R., et al.: Somatic mosaicism in the Wiskott-Aldrich syndrome: molecular and functional characterization of genotypic revertants. Clin Immunol<\/i>. 135<\/b>: 72-83, 2010."},{"key":"17","unstructured":"17) Boztug, K., et al.: Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome. Clin Genet<\/i>. 74<\/b>: 68-74, 2008."},{"key":"18","unstructured":"18) Lutskiy, M.I., et al.: Evolution of highly polymorphic T cell populations in siblings with the Wiskott-Aldrich Syndrome. PLoS ONE<\/i>. 3<\/b>: e3444, 2008."},{"key":"19","unstructured":"19) Trifari, S., et al.: Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs. J Allergy Clin Immunol<\/i>. 125<\/b>: 439-448, e8, 2010."},{"key":"20","unstructured":"20) Hirschhorn, R., et al.: Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery. Am J Hum Genet<\/i>. 55<\/b>: 59-68, 1994."},{"key":"21","unstructured":"21) Hirschhorn, R., et al.: Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet<\/i>. 13<\/b>: 290-295, 1996."},{"key":"22","unstructured":"22) Ariga, T., et al.: T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation. Blood<\/i>. 97<\/b>: 2896-2899, 2001."},{"key":"23","unstructured":"23) Arredondo-Vega, F.X., et al.: Adenosine deaminase deficiency with mosaicism for a \u201csecond-site suppressor\u201d of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy. Blood<\/i>. 99<\/b>: 1005-1013, 2002."},{"key":"24","unstructured":"24) Liu, P., et al.: Immunologic reconstitution during PEG-ADA therapy in an unusual mosaic ADA deficient patient. Clin Immunol<\/i>. 130<\/b>: 162-174, 2009."},{"key":"25","unstructured":"25) Moncada-Velez, M., et al.: Somatic mosaicism caused by monoallelic reversion of a mutation in T cells of a patient with ADA-SCID and the effects of enzyme replacement therapy on the revertant phenotype. Scand J Immunol<\/i>. 74<\/b>: 471-481, 2011."},{"key":"26","unstructured":"26) Stephan, V., et al.: Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. New Engl J Med<\/i>. 335<\/b>: 1563-1567, 1996."},{"key":"27","unstructured":"27) Bousso, P., et al.: Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor. Proc Natl Acad Sci U S A<\/i>. 97<\/b>: 274-278, 2000."},{"key":"28","unstructured":"28) Wada, T., et al.: Detection of T lymphocytes with a second-site mutation in skin lesions of atypical X-linked severe combined immunodeficiency mimicking Omenn syndrome. Blood<\/i>. 112<\/b>: 1872-1875, 2008."},{"key":"29","unstructured":"29) Speckmann, C., et al.: Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency. Blood<\/i>. 112<\/b>: 4090-4097, 2008."},{"key":"30","unstructured":"30) Kawai, T., et al.: Multiple reversions of an IL2RG mutation restore T cell function in an X-linked severe combined immunodeficiency patient. J Clin Immunol<\/i>. 32<\/b>: 690-697, 2012."},{"key":"31","doi-asserted-by":"publisher","unstructured":"31) Kuijpers, T.W., et al.: A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+<\/sup> T cells. Haematologica<\/i>. 98<\/b>: 1030-1038, 2013.","DOI":"10.3324\/haematol.2012.077511"},{"key":"32","unstructured":"32) Nishikomori, R., et al.: X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and\/or survival. Blood<\/i>. 103<\/b>: 4565-4572, 2004."},{"key":"33","unstructured":"33) Mizukami, T., et al.: Successful treatment with infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency. J Clin Immunol<\/i>. 32<\/b>: 39-49, 2012."},{"key":"34","unstructured":"34) Kawai, T., et al.: Frequent somatic mosaicism of NEMO in T cells of patients with X-linked anhidrotic ectodermal dysplasia with immunodeficiency. Blood<\/i>. 119<\/b>: 5458-5466, 2012."},{"key":"35","unstructured":"35) Tone, Y., et al.: Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1. Blood<\/i>. 109<\/b>: 1182-1184, 2007."},{"key":"36","unstructured":"36) Uzel, G., et al.: Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1). Blood<\/i>. 111<\/b>: 209-218, 2008."},{"key":"37","doi-asserted-by":"publisher","unstructured":"37) Wada, T., et al.: Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency. Blood<\/i>. 106<\/b>: 2099-2101, 2005.","DOI":"10.1182\/blood-2005-03-0936"},{"key":"38","unstructured":"38) Crestani, E., et al.: RAG1 reversion mosaicism in a patient with omenn syndrome. J Clin Immunol<\/i>. 34<\/b>: 551-554, 2014."},{"key":"39","unstructured":"39) Rieux-Laucat, F., et al.: Inherited and somatic CD3\u03b6 mutations in a patient with T-cell deficiency. New Engl J Med<\/i>. 354<\/b>: 1913-1921, 2006."},{"key":"40","unstructured":"40) Palendira, U., et al.: Expansion of somatically reverted memory CD8+<\/sup> T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus. J Exp Med<\/i>. 209<\/b>: 913-924, 2012."},{"key":"41","unstructured":"41) Jing, H., et al.: Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype. J Allergy Clin Immunol<\/i>. 133<\/b>: 1667-1675, 2014."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Davis, B.R., Candotti F.: Genetics. Mosaicism-switch or spectrum? Science<\/i>. 330<\/b>: 46-47, 2010.","DOI":"10.1126\/science.1195991"}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["\u539f\u767a\u6027\u514d\u75ab\u4e0d\u5168\u75c7\u306b\u304a\u3051\u308bRevertant somatic mosaicism"],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T05:34:04Z","timestamp":1498196044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/37\/6\/37_447\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.37.447","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}